TALPHERA, INC. — Director's Dealing 2014

Mar 11, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2014-03-02

Reporting Person: Hamel Lawrence G (Chief Development Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-02	Common Stock	F	1569	$11.43	Disposed	47834	Direct

Footnotes

F1: The shares were withheld to satisfy tax liability upon vesting 25% of the restricted stock units of the Company, previously reported on March 4, 2011.

F2: Balance includes non-reportable acquisition of 2,523 shares of Common Stock through the Company's Employee Stock Purchase Plan.